Sophie Van Linthout

10.1k total citations · 3 hit papers
137 papers, 6.2k citations indexed

About

Sophie Van Linthout is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Sophie Van Linthout has authored 137 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Cardiology and Cardiovascular Medicine, 48 papers in Molecular Biology and 47 papers in Surgery. Recurrent topics in Sophie Van Linthout's work include Viral Infections and Immunology Research (39 papers), Cardiovascular Function and Risk Factors (26 papers) and Cardiac Fibrosis and Remodeling (26 papers). Sophie Van Linthout is often cited by papers focused on Viral Infections and Immunology Research (39 papers), Cardiovascular Function and Risk Factors (26 papers) and Cardiac Fibrosis and Remodeling (26 papers). Sophie Van Linthout collaborates with scholars based in Germany, United States and Italy. Sophie Van Linthout's co-authors include Carsten Tschöpe, Kapka Miteva, Frank Spillmann, Bart De Geest, Leslie T. Cooper, Heinz‐Peter Schultheiß, Dirk Westermann, Kathleen Pappritz, Karin Klingel and Nasser A. Dhayat and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Sophie Van Linthout

131 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions

2020 699 citations Carsten Tschöpe, Enrico Ammirati et al. Nature Reviews Cardiology profile →
Crosstalk between fibroblasts and inflammatory cells

2014 444 citations Sophie Van Linthout, Kapka Miteva et al. Cardiovascular Research profile →
Inflammation – Cause or Consequence of Heart Failure or Both?

2017 330 citations Sophie Van Linthout, Carsten Tschöpe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sophie Van Linthout Germany	45	3.5k	1.9k	1.5k	795	595	137	6.2k
Susan S. Smyth United States	46	1.7k 0.5×	2.7k 1.4×	905 0.6×	1.2k 1.5×	236 0.4×	149	6.5k
Slava Epelman Canada	35	2.9k 0.8×	2.9k 1.5×	1.5k 1.0×	3.0k 3.8×	281 0.5×	65	8.2k
Michel Noutsias Germany	38	4.0k 1.1×	1.2k 0.6×	925 0.6×	667 0.8×	134 0.2×	148	5.7k
Domenico Corradi Italy	34	2.3k 0.7×	747 0.4×	1.8k 1.2×	578 0.7×	300 0.5×	128	5.5k
Naphtali Savion Israel	43	1.8k 0.5×	1.8k 0.9×	1.4k 0.9×	444 0.6×	488 0.8×	186	6.6k
Noel M. Caplice United States	43	877 0.2×	2.8k 1.4×	1.8k 1.1×	705 0.9×	223 0.4×	114	6.0k
Arne Yndestad Norway	47	2.5k 0.7×	3.5k 1.8×	1.2k 0.8×	2.3k 2.9×	385 0.6×	180	8.4k
Peter Liu Canada	30	1.8k 0.5×	1.7k 0.8×	883 0.6×	716 0.9×	120 0.2×	76	4.8k
Yoshiaki Taniyama Japan	41	1.7k 0.5×	2.3k 1.2×	1.6k 1.0×	383 0.5×	201 0.3×	101	6.0k
Daniel Sedding Germany	36	827 0.2×	1.9k 1.0×	771 0.5×	852 1.1×	204 0.3×	137	4.8k

Countries citing papers authored by Sophie Van Linthout

Since Specialization

Citations

This map shows the geographic impact of Sophie Van Linthout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Van Linthout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Van Linthout more than expected).

Fields of papers citing papers by Sophie Van Linthout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Van Linthout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Van Linthout. The network helps show where Sophie Van Linthout may publish in the future.

Co-authorship network of co-authors of Sophie Van Linthout

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Van Linthout. A scholar is included among the top collaborators of Sophie Van Linthout based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Van Linthout. Sophie Van Linthout is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pappritz, Kathleen, Li Guo, Valentina Fardella, et al.. (2025). Pericardial adipose tissue promotes transition to heart failure with reduced ejection fraction upon pressure-overload in mice. Basic Research in Cardiology. 120(5). 925–945.

Linthout, Sophie Van. (2024). Shared Mechanisms in Cancer and Cardiovascular Disease: S100A8/9 and the NLRP3 Inflammasome. JACC CardioOncology. 7(5). 501–513. 4 indexed citations

Heymans, Stéphane, Sophie Van Linthout, Sarah Kraus, Leslie T. Cooper, & Ntobeko Ntusi. (2024). Clinical Characteristics and Mechanisms of Acute Myocarditis. Circulation Research. 135(2). 397–411. 14 indexed citations

Geest, Bart De & Sophie Van Linthout. (2024). Non-HDL-cholesterol reduction: the challenges of applying clinical trial results in the real world. European Heart Journal. 45(39). 4216–4218. 1 indexed citations

Beetler, Danielle J., Katelyn A. Bruno, Damian N. Di Florio, et al.. (2023). Sex and age differences in sST2 in cardiovascular disease. Frontiers in Cardiovascular Medicine. 9. 1073814–1073814. 9 indexed citations

Pappritz, Kathleen, Sarah‐Lena Puhl, Muhammad El‐Shafeey, et al.. (2023). Sex- and age-related differences in the inflammatory properties of cardiac fibroblasts: impact on the cardiosplenic axis and cardiac fibrosis. Frontiers in Cardiovascular Medicine. 10. 1117419–1117419. 10 indexed citations

Elsanhoury, Ahmed, Uwe Kühl, Oliver Klein, et al.. (2022). The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention. Viruses. 14(2). 299–299. 11 indexed citations

Pappritz, Kathleen, Muhammad El‐Shafeey, Henry Fechner, et al.. (2022). Colchicine Prevents Disease Progression in Viral Myocarditis Via Modulating the NLRP3 Inflammasome in the Cardiosplenic Axis. ESC Heart Failure. 9(2). 925–941. 50 indexed citations

Pesce, Maurizio, Piergiuseppe Agostoni, Hans Erik Bøtker, et al.. (2021). COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovascular Research. 117(10). 2148–2160. 26 indexed citations

10.

Klingel, Karin, Stéphane Heymans, Sophie Van Linthout, et al.. (2021). Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?. Viruses. 13(6). 1003–1003. 11 indexed citations

11.

Tschöpe, Carsten, Enrico Ammirati, Biykem Bozkurt, et al.. (2020). Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature Reviews Cardiology. 18(3). 169–193. 699 indexed citations breakdown →

12.

Steffens, Sabine, Sophie Van Linthout, Joost P. G. Sluijter, et al.. (2020). Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function. Cardiovascular Research. 116(11). 1850–1862. 21 indexed citations

13.

Pappritz, Kathleen, Oliver Klein, Fengquan Dong, et al.. (2020). MALDI‐IMS as a Tool to Determine the Myocardial Response to Syndecan‐2‐Selected Mesenchymal Stromal Cell Application in an Experimental Model of Diabetic Cardiomyopathy. PROTEOMICS - CLINICAL APPLICATIONS. 15(1). e2000050–e2000050. 6 indexed citations

14.

Pabel, Steffen, Stefan Wagner, Philipp Bengel, et al.. (2018). Empagliflozin Directly Improves Diastolic Function in Human Heart Failure. European Journal of Heart Failure. 20(12). 1690–1700. 161 indexed citations

15.

Tschöpe, Carsten, Behrouz Kherad, Oliver Klein, et al.. (2018). Cardiac Contractility Modulation: Mechanisms of Action in Heart Failure with Reduced Ejection Fraction and Beyond. European Journal of Heart Failure. 21(1). 14–22. 70 indexed citations

16.

Miteva, Kapka, Rosalinda Madonna, Raffaele De Caterina, & Sophie Van Linthout. (2018). Innate and adaptive immunity in atherosclerosis. Vascular Pharmacology. 107. 67–77. 57 indexed citations

17.

Linthout, Sophie Van, Kapka Miteva, & Carsten Tschöpe. (2014). Crosstalk between fibroblasts and inflammatory cells. Cardiovascular Research. 102(2). 258–269. 444 indexed citations breakdown →

18.

Spillmann, Frank, Sophie Van Linthout, Kapka Miteva, et al.. (2013). LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effects. Atherosclerosis. 232(1). 1–9. 49 indexed citations

19.

Meloni, Marco, Andrea Caporali, Gallia Graiani, et al.. (2010). Nerve Growth Factor Promotes Cardiac Repair following Myocardial Infarction. Circulation Research. 106(7). 1275–1284. 157 indexed citations

20.

Linthout, Sophie Van, Frank Spillmann, Anna Foryst‐Ludwig, et al.. (2007). Increased high density lipoprotein cholesterol induced by human apolipoprotein A-1 gene transfer increases adiponectin expression in abdominal adipose tissue. Circulation. 116(16). 286–286. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact